<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / FDA Special Protocol Assessment / Prescription Drug User Fee Act / New Drug Application / FDA Fast Track Development Program / Center for Biologics Evaluation and Research / Meeting / Investigational New Drug / Validation / Food and Drug Administration / Medicine / Health
Pharmaceutical sciences
FDA Special Protocol Assessment
Prescription Drug User Fee Act
New Drug Application
FDA Fast Track Development Program
Center for Biologics Evaluation and Research
Meeting
Investigational New Drug
Validation
Food and Drug Administration
Medicine
Health

SOPP[removed]: Scheduling and Conduct of Regulatory Review Meetings with Sponsors and Applicants Version #5 Effective Date: October 15, 2012 I. Purpose

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 209,54 KB

Share Document on Facebook

Similar Documents

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

DocID: 1ogsZ - View Document

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

DocID: 1gkCa - View Document

   Global	
  Healthy	
  Living	
  Foundation	
   515	
  North	
  Midland	
  Avenue	
   Upper	
  Nyack,	
  New	
  York	
  10960	
  USA	
   +1	
  845	
  348	
  0400	
  

  Global  Healthy  Living  Foundation   515  North  Midland  Avenue   Upper  Nyack,  New  York  10960  USA   +1  845  348  0400  

DocID: 1g1KY - View Document

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

DocID: 1fuJJ - View Document

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DocID: 1aZ0Q - View Document